norfloxacin has been researched along with Gastritis in 2 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gill, HH | 1 |
Desai, HG | 1 |
Mehta, PR | 1 |
Ranganathan, S | 1 |
Kalro, RH | 1 |
Murti, PK | 1 |
Prabhu, SR | 1 |
Mertens, JC | 1 |
Dekker, W | 1 |
Ligtvoet, EE | 1 |
Blok, P | 1 |
1 trial available for norfloxacin and Gastritis
Article | Year |
---|---|
Mono and dual therapy for Helicobacter pylori associated gastritis.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; G | 1991 |
1 other study available for norfloxacin and Gastritis
Article | Year |
---|---|
Treatment failure of norfloxacin against Campylobacter pylori and chronic gastritis in patients with nonulcerative dyspepsia.
Topics: Campylobacter Infections; Chronic Disease; Dyspepsia; Gastritis; Humans; Norfloxacin | 1989 |